Orna Therapeutics
Orna Therapeutics is seeking a Project Manager on a contract basis to oversee and coordinate preclinical safety studies, including Toxicology, DMPK, and Bioanalytical functions, supporting the development of RNA therapeutics. The role involves tracking study timelines, managing documentation, and collaborating with internal teams and CROs to ensure timely and compliant study execution. It offers an opportunity to contribute to groundbreaking biotech research within a dynamic startup environment.
Headquarters
Watertown, Massachusetts, United States
Company Size
51-200 employees
Founded
2019
Orna Therapeutics is a biotechnology company creating fully engineered circular RNA (oRNA) therapeutics — an entirely new class of RNA medicines. The company designs and optimizes circular RNA molecules to enable durable, high‑level protein expression for applications such as vaccines, protein replacement, and cell therapies. Orna operates a platform-driven, engineering-first approach aimed at improving RNA stability, manufacturability, and translational potential to advance next‑generation medicines.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Orna Therapeutics.
Right around the average for this role
Director, Preclinical Immunology
Kernal Biologics, Inc.
Preclinical Study Manager
Revolution Medicines
Principal Scientist, DMPK/Tox
Nexagen Search
Director, DMPK- Pharmacokinetics & Clinical Pharmacology
iSi Environmental
Study Monitor - level D or E
ICON plc
Senior Manager Preclinical Study Management United States
alnylam